Search

Your search keyword '"Rückle, Thomas"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Rückle, Thomas" Remove constraint Author: "Rückle, Thomas"
142 results on '"Rückle, Thomas"'

Search Results

1. A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation

2. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study

3. The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors

4. The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.

5. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection

6. Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study

8. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

9. sj-pdf-1-msj-10.1177_13524585211024997 – Supplemental material for Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

10. sj-pdf-2-msj-10.1177_13524585211024997 – Supplemental material for Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

13. Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.

14. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers

17. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum

22. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

23. Improved safety margin for embryotoxicity in rats for the new endoperoxide artefenomel (OZ439) as compared to artesunate.

24. Phosphoinositide-3 kinase γ required for LPS-induced transepithelial neutrophil trafficking in the lung

26. Erratum: Corrigendum: The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors

27. PI3Kγ regulates cartilage damage in chronic inflammatory arthritis

29. Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development

30. Genetic and Pharmacological Targeting of Phosphoinositide 3-Kinase-γ Reduces Atherosclerosis and Favors Plaque Stability by Modulating Inflammatory Processes

34. Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ

35. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus

36. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

37. Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase

40. Cover Picture

45. Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human beta-cells.

48. Phosphoinositide 3-Kinase {gamma} Inhibition Plays a Crucial Role in Early Steps of Inflammation by Blocking Neutrophil Recruitment.

50. MOESM1 of A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

Catalog

Books, media, physical & digital resources